|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 0.3135 USD | +0.10% |
|
-9.89% | -38.53% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Healthcare Industry Software | ||||
Healthcare Software | - | - | - | 432K |
Total Assets | - | - | - | 84.18M |
Interest Expense | - | - | - | -4.08M |
Income Tax Expense | - | - | - | -1.99M |
EBT | - | - | - | -43.51M |
Gross Profit | - | - | - | 331K |
D&A | - | - | - | 492K |
Operating Income | - | - | - | -42.59M |
Net Income | - | - | - | -41.51M |
Interest Expense | - | - | -1.1M | - |
Net Income | - | - | 14.4M | - |
Total Assets | - | - | 3.52M | - |
Pharmaceutical Products | ||||
Interest Expense | - | - | -232K | - |
Net Income | - | - | -3.51M | - |
Total Assets | - | - | 98.07M | - |
Pharmaceutical Product Distribution | ||||
Integra | - | - | 137K | - |
Total Assets | - | - | 3.26M | - |
Gross Profit | - | - | 6K | - |
D&A | - | - | 2K | - |
Net Income | - | - | -1.83M | - |
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
United States | 300K | 800K | 137K | 432K |
Total Assets | 605K | 1.25M | 105M | 84.18M |
Interest Expense | -76.35K | -313K | -1.34M | -4.08M |
Income Tax Expense | - | - | -534K | -1.99M |
D&A | - | - | 53.36K | 492K |
CAPEX | - | - | -12K | - |
Gross Profit | - | - | 6K | 331K |
Net Income | -3.71M | -2.24M | 9.07M | -41.51M |
EBT | -3.71M | -2.24M | -18.78M | -43.51M |
Operating Income | -3.64M | -1.95M | -14.7M | -42.59M |
- Stock Market
- Stocks
- SCNX Stock
- Financials Scienture Holdings, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
